Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection
- PMID: 37026018
- PMCID: PMC10072902
- DOI: 10.3389/fimmu.2023.1183107
Erratum: The efficacy of cancer immunotherapies is compromised by Helicobacter pylori infection
Abstract
[This corrects the article DOI: 10.3389/fimmu.2022.899161.].
Keywords: Helicobacter pylori; cancer; gut microbiota; immune checkpoint inhibitors; immunotherapy, personalized medicine.
Copyright © 2023 Frontiers Production Office.
Erratum for
-
The Efficacy of Cancer Immunotherapies Is Compromised by Helicobacter pylori Infection.Front Immunol. 2022 May 23;13:899161. doi: 10.3389/fimmu.2022.899161. eCollection 2022. Front Immunol. 2022. PMID: 35677057 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources